PriMED Clinical Research A fib and A flutter

Study Name: LILAC-TIMI 76 by Anthos Therapeutics, Inc.

Purpose:

Looking for participants between the ages of 65+ with atrial flutter or atrial fibrillation! This study is looking at whether abelacimab can help prevent strokes or blood clots that travel through the body (systemic embolism) in people with atrial flutter or atrial fibrillation (AF).

The study includes patients who, either based on their doctor's recommendation or their own choice, cannot take or are not suitable for standard blood-thinning medications (oral anticoagulants).

 

What to Expect in Clinical Trial: 

Participating in a clinical trial is a voluntary way to help researchers learn more about new medications, treatments, or ways to prevent disease.
Some studies offer compensation for time and travel.
Contact our study team for more information

Location: PriMED Clinical Research

 

A young boy with Down syndrome smiles happily while sitting at a table and playing with a yellow toy camel.

FAQs

We believe this study will potentially benefit our patients and future patients.

Looking for participants between the ages of 65+ with atrial flutter or atrial fibrillation! This study is looking at whether abelacimab can help prevent strokes or blood clots that travel through the body (systemic embolism) in people with atrial flutter or atrial fibrillation (AF).

You will be asked to come into our Research Clinic to participate.  All study procedures and assessments will be at no cost to you or your insurance.

Participants may receive compensation for their time and travel expenses.

Visits will be located at our PriMED Clinical Research office:

PriMED Clinical Research
3080 Ackerman Blvd, Suite 210
Dayton, Ohio 45429

If you are interested in learning more about how to sign up for the PriMED Clinical Research, please call (937) 534-4201 and speak to a member of the research team, or simply fill out our online interest form.

Prequalify for Clinical Research